Ticker Scorecard - NRIX Basics Company: Nurix Therapeutics, Inc. IPO Date: July 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.28B Activated in VL: True Average Daily Range Avg Daily Range: $0.74 | 3.59% Avg Daily Range (30 D): $0.43 | 2.30% Avg Daily Range (90 D): $0.51 | 2.35% Institutional Daily Volume Avg Daily Volume: .41M Avg Daily Volume (30 D): .55M Avg Daily Volume (90 D): .71M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 54 Avg Trade Size (Sh.) (90 D): 67 Institutional Trades Total Inst.Trades: 1,463 Avg Inst. Trade: $2.07M Avg Inst. Trade (30 D): $1.57M Avg Inst. Trade (90 D): $2.93M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $1.87M Avg Closing Trade (90 D): $2.65M Avg Closing Volume: 102.65K     News Feb 4, 2025 @ 12:00 PM Nurix Therapeutics to Participate in the Oppenheim... Source: N/A Jan 28, 2025 @ 9:00 PM Nurix Therapeutics Reports Fourth Quarter and Fisc... Source: Nurix Therapeutics, Inc. Nov 20, 2024 @ 9:00 PM Nurix Therapeutics Receives PRIME Designation from... Source: N/A Nov 17, 2024 @ 3:30 PM Nurix Therapeutics Presents Preclinical Data from ... Source: Nurix Therapeutics, Inc. Oct 19, 2024 @ 12:00 PM Nurix Therapeutics Presents Positive Results from ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.9 $-.67 $-.71 Diluted EPS $-2.9 $-.67 $-.71 Revenue $ 56.42M $ 12.59M $ 12.09M Gross Profit $ $ $ Net Income / Loss $ -176.98M $ -48.96M $ -44.55M Operating Income / Loss $ -193.7M $ -54.61M $ -48.54M Cost of Revenue $ $ $ Net Cash Flow $ 56.74M $ -17.75M $ 66.98M PE Ratio